Resistin, Acute Coronary Syndrome and Prognosis Results from the Atherogene Study.
From: Department of Medicine II, Johannes Gutenberg-University Mainz, Langenbeckstr. 1, 55131 Mainz, Germany.
Atherosclerosis
- Publish Date: Jul 2007
- ISSN: 0021-9150
- Volume: 193
- Issue: 1
- Pages: 121-8
- Medium: Print
- Language: English
- Citation (JAMA): Lubos Edith, Messow Claudia M, Schnabel Renate, et al. Resistin, Acute Coronary Syndrome and Prognosis Results from the Atherogene Study.. Atherosclerosis Jul 2007;193:121-8
Abstract
OBJECTIVE: Resistin, an adipocyte and macrophage derived cytokine, causes insulin resistance and glucose intolerance. We investigated the impact of resistin as a diagnostic marker in patients with acute coronary syndrome and its prognostic value for future cardiovascular events. METHODS: Resistin levels were determined in 1153 patients with stable angina (SAP), 380 patients with unstable angina, 278 patients with non-ST-elevation myocardial infarction (NSTEMI) and 111 patients with ST-elevation myocardial infarction (STEMI). All patients have been followed up for a median follow-up of 2.6 years. During follow-up, 70 patients died from cardiovascular causes. RESULTS: Compared to SAP, resistin levels (5.1 ng/mL in SAP) were elevated in patients with angina at rest (5.89 ng/mL, P=0.001), in patients with NSTEMI (6.00 ng/mL, P<0.001), and in patients with STEMI (5.98 ng/mL, P<0.001). Resistin levels rose at 3-6h after chest pain onset (5.46 ng/mL), persisted elevated among those individuals presenting between 6 and 12h after chest pain onset (5.57 ng/mL) and peaked in individuals presenting more than 12h after chest pain onset (5.74 ng/mL). An increase of one standard deviation of resistin levels was associated with a 1.22-fold (95% CI 1.04-1.43; P=0.02) risk for future fatal cardiovascular events in a model adjusted for risk factors and clinical and therapeutic variables. When adjustment for renal function was applied, this association lost its statistical significance. CONCLUSIONS: Resistin levels are elevated in patients presenting with unstable angina, NSTEMI and STEMI and might play a role as a diagnostic marker. In addition, systemic resistin level is moderately associated with future cardiovascular death in patients with documented coronary artery disease.
Mesh Headings (Keywords): Acute Disease, Aged, Angina Pectoris, Angina, Unstable, Biological Markers, Coronary Disease, Electrocardiography, Female, Humans, Inflammation Mediators, Lipids, Male, Middle Aged, Myocardial Infarction, Prognosis, Resistin, Risk Factors, Syndrome
Check for Full Text / PubMed Unique Identifier (PMID): 16814296
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.